Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y012508 | OT |
No additional AE reported.; patient was administered GARDASIL9 during a temperature excursion.; This spontaneous report was received from a non-health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 25-Apr-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant Injection (GARDASIL 9) 1 dose (route of administration, vaccination site, and vaccination scheme were not provided; lot #Y012508 which has been verified to be a valid number, expiration date reported and validated as 01-Jan-2027) as a prophylaxis. The vaccine administered was stored at temperature of 0 degrees Celsius (C) for a time frame of 1 hours. It was unknown if a data logger was used. There was no previous temperature excursion. No additional AE details were reported.